Focused ultrasound has the potential to improve treatment of cardiovascular disorders, including hypertension, thrombosis and atrial fibrillation; clinical and basic research is ongoing.

For patients with drug-resistant hypertension, pilot clinical research has demonstrated the potential of focused ultrasound to non-invasively reduce hypertension by destroying the nerves that control blood pressure, located around the artery leading to the kidney.

Preclinical research has also shown that focused ultrasound can liquefy blood clots, either independently or in combination with bubbles and anti-clotting agents, possibly being used to restore blood flow to regions of the brain affected by stroke, or treating arterial or deep vein thrombosis.

For patients with cardiac arrhythmias, the technology may have the potential to block the electrical pathway from the atrium to the heart via thermal ablation, providing rate control management for patients with chronic atrial fibrillation and similar conditions. 

Learn more about focused ultrasound for:

clinical stages key
Atherosclerosis Early Stage icon  
Atrial Fibrillation Early Stage icon  
Arteriovenous Malformations (AVM's) Clinical Trials icon  
Cardiac Pacing Early Stage icon  
Cardiac Hypertrophy Early Stage icon  
Congestive Heart Failure Early Stage icon  
Deep Vein Thrombosis (DVT) Early Stage icon  
Heart Valve Calcifications
Early Stage icon  
Hypertension Outside Approval icon Clinical Trials icon
Hypoplastic Left Heart Syndrome Early Stage icon  
Peripherial Artery Disease Clinical Trials icon  
Septal Perforation Early Stage icon  
Varicose Veins Clinical Trials icon